Stimulation of 3T3-L1 Adipogenesis by Signal Transducer and Activator of Transcription 5
Rika Nanbu-Wakao,
Yoshihiro Morikawa,
Itaru Matsumura,
Yasuhiko Masuho,
Masa-aki Muramatsu,
Emiko Senba and
Hiroshi Wakao
Helix Research Institute (R.N.-W., Y. Ma., H.W.), 1532-3 Yana Kisarazu-shi Chiba, 292-0812 Japan; The Second Department of Anatomy (Y. Mo., E.S.), Wakayama Medical College, Kimiidera, Wakayama 641-0012, Japan; Department of Hematology and Oncology (I.M.), Faculty of Medicine, University of Osaka, Yamadaoka Suita-shi Osaka 565-0871, Japan; and Hubid Genome Systems Co. (M.-A.M.), Hirakawa-cho, Chiyoda-ku, Tokyo 102-0093, Japan
Address all correspondence and requests for reprints to: Hiroshi Wakao, Ph.D., Laboratory of Immune Regulation, Riken Research Center for Allergy and Immunology, c/o Department of Molecular Immunology, School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku Chiba, 260-8670 Japan. E-mail: hwakao{at}med.m.chiba-u.ac.jp.
 |
ABSTRACT
|
---|
Signal transducer and activator of transcription 5 (Stat5) mediates signaling of many cytokines and growth factors. Here we show that Stat5 functions as an initial mediator of adipogenesis. The preadipocyte cell line 3T3-L1 undergoes adipocyte differentiation upon appropriate hormonal induction. We found that Stat5A and Stat5B were strongly activated at an early stage of 3T3-L1 differentiation. To investigate physiological roles of Stat5 in adipogenesis, we have constructed 3T3-L1 cell lines in which either an exogenous wild type (wt) or dominant negative (dn) form of Stat5A expression was controlled under the doxycycline-regulatable promoter. Precocious induction of wt-Stat5A in adipocyte differentiation promoted accumulation of triglycerides within the cells. In contrast, induction of dn-Stat5A attenuated lipid accumulation. Northern blot analyses revealed that the expression of proadipogenic transcription factors was influenced in a complementary fashion by ectopic expression of either wt- or dn-Stat5A. Notably, Stat5 regulated expression of peroxisome proliferator-activated receptor-
, which plays crucial roles in adipogenesis. We have also generated transgenic mice in which dn-Stat5A is expressed in an adipose tissue-specific fashion and found attenuation of peroxisome proliferator-activated receptor-
and of many adipocyte-related genes. These results highlight a novel role of Stat5 in adipocyte differentiation.
 |
INTRODUCTION
|
---|
ADIPOCYTES PLAY IMPORTANT roles in synthesis, storage, and hydrolysis of nutritional energy. Adipocytes store triglycerides during periods of caloric excess but mobilize this reserve during caloric insufficiency. Throughout development, adipocytes acquire a full complement of enzymes and accessory proteins to carry out de novo lipogenesis, lipoprotein hydrolysis, intracellular fatty acid transport, and lipolysis (1). In addition to storing lipids, adipocytes secrete numerous bioactive molecules such as leptin, TNF
, resistin, and adiponectin (2, 3, 4). Among these, leptin mediates the satiety signal in regulation of energy metabolism, whereas TNF
and resistin are involved in insulin resistance in obesity (2, 5, 6). Adipocytes also take up and release glycerol and free fatty acids, which contribute to regulation of hepatic and peripheral glucose metabolism. With regard to glucose homeostasis, adipose tissue along with heart and skeletal muscle are the only tissues known to express and regulate the insulin-dependent glucose transporter 4, which facilitates the entry of glucose into these cells and out of the circulation postprandially (7). Therefore, the adipocyte differentiation program comprises regulation of genes involved in all aspects of molecular events such as cell morphology, storage and release of triglycerides, glucose metabolism, and energy homeostasis.
Obesity, which is marked by an excessive accumulation of adipose tissues, affects many Western countries, is a major risk factor of insulin resistance, and contributes to pathological states such as diabetes, hypertension, and cardiovascular disease. Hence, a better understanding of the molecular basis for adipocyte differentiation opens a door to the development of therapeutic interventions.
Adipogenesis is a complex process controlled by the interplay of signals emanating from both environmental and intracellular factors (8, 9, 10). Preadipocyte cell lines such as 3T3-L1 and 3T3-F422A have served as in vitro models to delineate complex cascades of transcriptional events during the differentiation process. Three classes of transcription factors have been identified that directly influence fat cell development. These include CCAAT-enhancer binding proteins (C/EBPs), the nuclear hormone receptor peroxisome proliferator-activated receptor-
(PPAR
), and adipocyte determination differentiation factor 1/sterol response element binding protein-1c (ADD1/SREBP-1c) (8, 9, 10, 11). Among these, C/EBPß and -
are induced at an early stage of adipogenesis and required for subsequent fulfillment of the adipogenic program (12, 13, 14). In vitro study has demonstrated that ectopic expression of C/EBPß and, to a lesser extent, C/EBP
leads to the conversion of preadipocytes or NIH-3T3 cells into adipocytes (13, 14). Gene knockout experiments have indicated that ablation of either C/EBPß or -
isoform results in a slight reduction in the adipogenic potential of embryonic fibroblasts, whereas depletion of both leads to severe impedance (15). C/EBP
is induced relatively late in differentiation, after the induction of PPAR
but before the synthesis of many enzymes and proteins characteristic of fully differentiated cells (9). As in the case of C/EBPß, ectopic expression of C/EBP
in fibroblasts is sufficient to convert them into adipocytes (16, 17). Furthermore, C/EBP
knockout mice display dramatically reduced fat accumulation in white adipose tissue (WAT) and brown adipose tissue (BAT) (18). These findings demonstrate that C/EBPs play a vital role in fat cell development. At present, it is thought that induction of C/EBPß and -
is prerequisite for the subsequent expression of PPAR
(19). Gain-of-function experiments have shown that overexpression of PPAR
in the presence of its agonists is sufficient to induce adipogenesis in a variety of cell types including fibroblasts and myoblasts (20, 21). In addition, gene ablation experiments disclosed an essential role of PPAR
in the formation of fat (22, 23, 24). ADD1/SREBP-1c is a third transcription factor associated with adipogenesis (25). It is also reported that ectopic expression of ADD1 in fibroblasts leads to their conversion into adipocytes in the presence of the PPAR
agonists (26). Recent experiments have proposed that ADD1/SREBP-1c activates PPAR
expression directly or through the production of an endogenous ligand, thus enabling cells to differentiate into adipocytes (27, 28).
It is clear that these factors function as proadipogenic factors in adipogenesis. One has to keep in mind, however, that all these factors are undetectable or expressed at very low levels before differentiation, and their expression increases only after the induction of adipogenesis. It is highly conceivable, therefore, that the expression of these factors is controlled and coordinated by protein(s) present before adipogenic stimulation. Although C/EBPß and -
are assumed to be required for PPAR
induction, in vivo data from the C/EBPß and -
double knockout mice indicate that there must be C/EBPß- and
-independent pathway(s) leading to PPAR
and C/EBP
expression (15). 3T3-L1 cells undergo differentiation upon challenge with an adipogenic hormone cocktail consisting of methylisobutylxanthine (MIX), dexamethasone (DEX), insulin, and fetal bovine serum (FBS). Because MIX and DEX are direct inducers for C/EBPß and -
, respectively, we hypothesized that factors posttranslationally activated by FBS may play a role in adipogenesis together with C/EBPß and -
(12). As adipocytes contain several cytokine receptors such as the GH and the prolactin receptors (29, 30), we assumed that downstream molecule(s) underpinning the function of these receptors might be a candidate molecule(s). We have hypothesized that signal transducer and activator of transcription 5 (Stat5), a prolactin/GH-signaling mediator, may play a role in adipogenesis. This hypothesis is based on our previous report that prolactin stimulates NIH3T3 adipogenesis (31). Stat5 is composed of two highly homologous genes, Stat5A and Stat5B, and is used as a signal transducer by a variety of cytokines and growth factors (32, 33). It has been shown also that Stat5 as well as Stat1 proteins are up-regulated during the adipogenic conversion of 3T3-L1 or NIH-3T3ß/
cells, whereas Stat3 and Stat6 expression remains constant (34, 35). These observations suggested that Stat5 is involved in adipose cell development. In this report, we have constructed conditional expression systems in which the expression of either a wild-type (wt) or a dominant negative (dn) form of Stat5A was regulated under the doxycycline (Dox)-controlled promoter in 3T3-L1 cells (36). These systems allowed us to evaluate some roles of Stat5 in adipocyte differentiation. Our current experiments demonstrated that Stat5A and B were strongly activated at an early stage of differentiation, and ectopic expression of Stat5A influenced expression of PPAR
, which ultimately resulted in altered triglyceride accumulation at a later stage of differentiation of 3T3-L1 cells. To further support the in vitro data, we have generated transgenic mice in which dn-Stat5A is expressed in an adipose tissue-specific manner. We found that overexpression of dn-Stat5A in adipose tissues also compromised expression of PPAR
. These data demonstrate that Stat5 regulates, at least in part, adipogenesis through controlling the expression of PPAR
.
 |
RESULTS
|
---|
Activation of Stat5A and Stat5B during 3T3-L1 Cell Differentiation
To investigate whether Stat5s are involved in adipogenesis, we first examined activation of these proteins upon adipogenic hormone challenge by immunoprecipitation followed by 4G10 blotting. Stat5A and B were present in 3T3-L1 cells before differentiation induction and throughout differentiation (Fig. 1
). Stat5A was strongly tyrosine phosphorylated at 1 h after hormone treatment, and this high level of activation was maintained for up to 3 h (Fig. 1
, lanes 2 and 3, upper panel). By 24 h, however, the degree of phosphorylation was slightly attenuated (Fig. 1
, lane 4, upper panel). Thereafter, a small increment of tyrosine phosphorylation was observed up to 120 h (lanes 57, upper panel). Even at 192 h, Stat5A was still tyrosine phosphorylated, although the degree was much less than that at 3 h (Fig. 1
, lane 8, upper panel). In the lower panel, Stat5s ran as a doublet, the 95 kDa and 92 kDa, corresponding to Stat5A and Stat5B, respectively. Both Stat5A and Stat5B were strongly tyrosine phosphorylated at 1 h post hormone treatment, and this high level of activation was maintained for up to 3 h (Fig. 1
, lanes 2 and 3, lower panel). Subsequently the tyrosine-phosphorylated 92-kDa band (Stat5B) gradually extinguished, whereas the 95-kDa band (Stat5A) was kept tyrosine phosphorylated, albeit weakly. Intriguingly, Western blot analysis revealed that Stat5A and Stat5B expression was augmented from 48 h post adipogenic challenge toward the end of differentiation, and these findings were in line with a previous report (Fig. 1
, lanes 58, upper and lower panels) (34). We have also confirmed that no Stat5A and B remained in the cell lysates after immunoprecipitation (data not shown). It is noteworthy that the ratio between tyrosine-phosphorylated Stat5s and unphosphorylated Stat5s decreased as cells converted into adipocytes (Fig. 1
, lanes 28, upper and lower panels). Other Stats, such as Stat1 and Stat3, were not activated during adipogenic conversion of 3T3-L1 cells (data not shown). These results showed that Stat5A and Stat5B were activated upon adipogenic hormone stimulation and that activation of Stat5A was sustained during adipogenic conversion of 3T3-L1 cells.

View larger version (58K):
[in this window]
[in a new window]
|
Figure 1. Stat5A and Stat5B Activation during Adipocyte Differentiation
3T3-L1 preadipocytes were grown to confluence and left for 2 d before adipogenic hormone challenge with 10% FBS, insulin, DEX, and MIX. Thereafter, the cells were refed every other day with medium containing 10% FBS and 2.5 µg/ml of insulin. Cell lysates were prepared at the indicated time points, and 2 mg of protein were used for immunoprecipitation with anti-Stat5A (L-20) or Stat5B (C-17) antibody. Note that L-20 reacts with Stat5A, whereas C-17 recognizes both Stat5A and Stat5B. Precipitated proteins were blotted with the antiphosphotyrosine antibody 4G10. After stripping, membranes were blotted with the respective antibody.
|
|
Establishment and Characterization of the Reverse Tetracycline-Controlled Stat5 Expression Systems in 3T3-L1 Preadipocyte Cells
Stat5 activation during 3T3-L1 differentiation suggested that Stat5 plays some role in adipogenesis. To directly assess whether Stat5 participates in adipogenesis, 3T3-L1 cells were engineered to express Stat5 proteins using the reverse tetracycline-controlled transactivator (36). This system allows relatively tight induction of the desired protein in the presence of the inducer. We have generated a number of 3T3-L1 cell lines that inducibly expressed wild type (wt)- or dominant negative (Y694F) (dn)-Stat5A upon Dox addition (37, 38, 39). Several independent clones were analyzed, and clones that retained a similar differentiation potential as parental cells were used for further analysis. Results with a representative clone for wt-Stat5A- and dn-Stat5A-expressing cells designated L1-wt-Stat5 and L1-dn-Stat5 cells, respectively, are shown. Expression of exogenous Stat5A in L1-wt-Stat5 and L1-dn-Stat5 cells was determined by Western blot analysis (Fig. 2A
). Dox treatment resulted in a 5-fold increase for wt- and dn-Stat5A in 48 h (Fig. 2A
, lanes 13). We found that maximal induction of both wt- and dn-Stat5A proteins lasted for 4872 h. Thereafter, expression of wt- and dn-Stat5A gradually diminished even in the continuous presence of Dox (Fig. 2A
, lanes 26). Dox had no effect on Stat5 protein expression in the control cells (termed "parent") stably transfected with reverse tetracycline-controlled transactivator (rtTA) alone (data not shown).

View larger version (29K):
[in this window]
[in a new window]
|
Figure 2. Characterization of Dox-Inducible wt- and dn-Stat5A in 3T3-L1 cells
A, Time course of wt- and dn-Stat5A expression in L1-wt-Stat5 and L1-dn-Stat5 cells upon Dox induction. Cells were cultured as described in Materials and Methods. After reaching confluency, cells were treated with Dox (1 µg/ml) in DMEM containing 10% calf serum. Western blot analysis was performed using C17 antibody with total cell extracts (4 µg) prepared from the indicated time point. As seen in Fig. 1 , there are two bands corresponding to dn-Stat5A and B in both cell lines. B, Effect of exogenous Stat5 on a Stat5-reporter gene transcription. Parent, L1-wt-Stat5, and L1-dn-Stat5 cells were cultured in the presence (+) or absence (-) of Dox for 2 d before transfection with a Stat5-reporter gene. After serum starvation, cells were left untreated or challenged with OPTIMEM containing 10% FBS or prolactin (PRL) (1 µg/ml) and incubated for another 6 h in the presence (+) or absence (-) of Dox. Relative luciferase activities with SDs are shown. Transfections were performed in triplicate and repeated four times. C, Effect of exogenous Stat5 on cell proliferation. L1-wt-Stat5 and L1-dn-Stat5 cells were grown to confluence and incubated with or without Dox for 48 h before adipogenic hormone treatment. Thereafter, cells were refed with culture medium as described in Fig. 1 in the presence or absence of Dox. Cell number was counted every day. Data represent relative cell number and are shown as the means of three independent experiments performed in triplicate. SDs are indicated with error bars.
|
|
After L1-wt-Stat5 and L1-dn-Stat5 cells had been established, a Stat5-dependent reporter gene assay was performed to address whether overexpression of exogenous Stat5A interfered in the endogenous Stat5 signaling pathway. Parent, L1-wt-Stat5, and L1-dn-Stat5 cells were transiently transfected with a firefly luciferase reporter gene that shows Stat5-dependent transactivation (40). In the absence of Dox, challenge with prolactin or FBS stimulated the luciferase activity by 7.0- and 5.3-fold in parent cells, respectively (Fig. 2B
, Parent, Dox [-], PRL, and FBS). Similarly, challenge with prolactin or FBS stimulated the luciferase activity by 5.2- and 4.4-fold in L1-wt-Stat5 cells, respectively (Fig. 2B
, L1-wt-Stat5, Dox [-], PRL, and FBS). Likewise, prolactin and FBS stimulated the luciferase activity by 7.1- and 5.6- fold in L1-dn-Stat5 cells, respectively (Fig. 2B
, L1-dn-Stat5, Dox [-], PRL, and FBS). Addition of Dox did not affect the prolactin- and the FBS-induced transcriptional activity in parent cells (Fig. 2B
, Parent, Dox [+], PRL, and FBS). When wt-Stat5A expression was induced, both prolactin- and FBS-dependent luciferase activities resulted in a further 2.0-fold increase (Fig. 2B
, L1-wt-Stat5, Dox [+], PRL, and FBS). We also found a 3-fold increment in basal luciferase activity by Dox in L1-wt-Stat5 cells (Fig. 2B
, L1-wt-Stat5, Dox [-] and [+], None). On the contrary, when dn-Stat5A was induced, both prolactin- and FBS-stimulated luciferase activities were repressed to 44% and 67%, respectively, of their control values (Fig. 2B
, L1-dn-Stat5; compare Dox [-] and [+], PRL, and FBS). These results showed that exogenous Stat5A indeed influenced endogenous Stat5 signaling pathways, thus advocating the validity of this system.
Stat5 has been shown to be responsible for cell growth dependent on several cytokines; thus a possible mechanism by which Stat5 affects adipogenesis would be by promoting or inhibiting cell proliferation during clonal expansion (41, 42). To assess this possibility, we compared cell numbers before and after differentiation stimulation (d 04), in the presence or absence of Dox in L1-wt-Stat5 and L1-dn-Stat5 cells. As shown in Fig. 2C
, there was about a 3-fold increase in cell number after adipogenic challenge, which is normally observed during mitotic clonal expansion of preadipocyte cells (Fig. 2C
, compare d 0 and d 3) (43). Proliferation of L1-wt-Stat5 and L1-dn-Stat5 cells was not significantly affected regardless of Dox presence (Fig. 2C
). We also found that the doubling time for L1-dn-Stat5 cells was slightly slower than that for L1-wt-Stat5 cells (Fig. 2C
); however, no apparent effect of Dox was observed. When cell number was compared in the growing phase, the same results were obtained (data not shown). Because Stat5 controls the expression of several genes required for cell cycle progression in hematopoietic cells (42, 44), we evaluated whether wt- or dn-Stat5A affects the expression of these genes. Northern Blot analysis indicated that the expression levels of c-fos, cyclin A, B, D1, E, p21, and p27 were not influenced by either wt-Stat5A or dn-Stat5A (data not shown). These data suggested that Stat5 activation was not related to mitogenesis of 3T3-L1 cells.
Stat5 Exerts Its Stimulatory Role in Adipogenesis at Initial Stages of Differentiation
We then hypothesized that the expression of wild-type Stat5A would stimulate adipogenesis, whereas dn-Stat5A would inhibit differentiation. This hypothesis was first tested in experiments in which triglyceride storage was monitored as an index of adipose differentiation by Oil Red O staining (Fig. 3A
). In the absence of Dox, L1-wt-Stat5 and L1-dnStat5 cells exhibited triglyceride accumulation and large, rounded morphology 9 d after exposure to a differentiation cocktail (Fig. 3A
, microscopic view, Dox-). Macroscopic analysis also revealed the similar degree of differentiation of both cell lines as judged from Oil Red O staining (Fig. 3A
, macroscopic view, Dox-). Thus, each cell line possessed normal differentiation potential. In L1-wt-Stat5 cells, the number of cells accumulating triglycerides increased when Dox was added before exposure to the differentiation cocktail (Fig. 3A
, microscopic and macroscopic view, Dox+). On the contrary, ectopic expression of dn-Stat5A decreased the cell population undergoing adipogenesis (Fig. 3A
, microscopic and macroscopic view, Dox+). Parent cells showed no difference in the differentiation potential regardless of Dox presence (data not shown). These observations suggested that Stat5 modulated adipogenesis. Because Stat5 was strongly activated at an early stage of adipogenesis (Fig. 1
), we have tried to define the time window during which Stat5 exerted its effect on adipogenesis. wt-Stat5A expression was induced at different time points during the adipogenic regimen, and resulting triglyceride contents were compared (Fig. 3B
). It must be noted that it takes 48 h to maximally induce exogenous Stat5A with Dox. When Dox was added 48 h before adipogenic hormone challenge, the relative amount of triglycerides was augmented to 1.8-fold over the control in L1-wt-Stat5 cells (Fig. 3B
, left panel, compare - and -2 d). Addition of Dox on the same day as adipogenic hormone treatment resulted in a 30% increment of triglyceride contents relative to the control (Fig. 3B
, left panel, compare - and 0 d). In contrast, when adipogenic induction preceded Dox treatment by 2 d, little enhancement of triglyceride accumulation was observed (Fig. 3B
, left panel, compare - and +2 d). We also assessed the effects of dn-Stat5A on triglyceride loading in the cells by the same protocol (Fig. 3B
, middle panel). When Dox was added 48 h before adipogenic hormone challenge, the relative amount of triglycerides was reduced to 67% over the control (Fig. 3B
, middle panel, compare - and -2 d). Addition of Dox on the same day as adipogenic hormone treatment resulted in a 21% decrement of triglyceride contents relative to the control (Fig. 3B
, middle panel, compare - and 0 d). In contrast, when adipogenic induction preceded Dox treatment by 2 d, little reduction of triglyceride accumulation was observed (Fig. 3B
, middle panel, compare - and +2 d). Addition of Dox to parental cells did not alter the triglyceride content, implying that Dox alone had no impact on differentiation (Fig. 3B
, right panel). These data demonstrated that Stat5 exerted its proadipogenic effect during early phases of differentiation, which correlated well with its strong activation periods (Figs. 1
and 3B
).

View larger version (57K):
[in this window]
[in a new window]
|
Figure 3. Effect of Stat5A on Triglyceride Loading
A, Ectopic expression of wt-Stat5A stimulates adipogenesis, whereas dn-Stat5A overexpression inhibits adipogenesis as determined by triglyceride storage. L1-wt-Stat5 (WT) and L1-dn-Stat5 (DN) cells were cultured for 48 h in the presence (+) or absence (-) of Dox after reaching confluence. Cells were challenged with the adipogenic hormone cocktail as described in Fig. 1 . After 9 d, cells were stained with Oil Red O to visualize triglyceride vesicles (upper panel, microscopic view; lower panel, macroscopic view). B, Stat5 exerts its effects on triglyceride accumulation at an early phase of adipocyte differentiation. Parent, L1-wt-Stat5, and L1-dn-Stat5 cells were grown to confluence and induced to differentiate as described in Fig. 1 . Treatment with Dox was started at the indicated day, resulting in different pulses of elevated Stat5A expression (upper panel). After 9 d, triglycerides were extracted from the cells and quantitated as described in Materials and Methods. Results are shown as the means of five experiments done in triplicate with SD error bars. Triglyceride content relative to the control (in the absence of Dox) is shown (lower panel).
|
|
Stat5 Modulates Expression of the Proadipogenic Transcription Factors
How is Stat5 involved in adipogenesis? Most likely, this process occurs through the activation of the gene cascade leading to expression of the adipocyte genes. To gain a mechanistic insight, we analyzed whether wt- or dn-Stat5A overexpression during the early phase of differentiation altered expression of the proadipogenic transcription factors. C/EBPß and
are the initial factors transcriptionally induced upon adipogenic hormone challenge and are thought to be required for PPAR
expression (12, 19). Administration of adipogenic hormones led to the immediate transcriptional activation of C/EBPß and -
, as reported (Fig. 4A
, lanes 1 and 2 and lanes 6 and 7, C/EBPß and C/EBP
) (12). The increased level of C/EBPß and
were maintained up to 2 d and then declined by 4 d in both L1-wt-Stat5 and L1-dn-Stat5 cells (Fig. 4A
, lanes 35, C/EBPß and C/EBP
). Addition of Dox caused no change in the expression levels of these factors in both cells (Fig. 4A
, compare lanes 15 and lanes 610, C/EBPß and C/EBP
). These data clearly demonstrated that Stat5 had little influence on C/EBPß and -
expression. PPAR
mRNA was induced very early (12 d postconfluence) during the differentiation of both L1-wt-Stat5 and L1-dn-Stat5 cells (Fig. 4A
, lanes 15, PPAR
). Addition of Dox to L1-wt-Stat5 cells robustly stimulated the level of PPAR
from d 1 to d 9 (Fig. 4A
, compare lanes 25 and lanes 710). In contrast, addition of Dox to L1-dn-Stat5 cells decreased PPAR
from d 1 to d 9 (Fig. 4A
, compare lanes 25 and lanes 710). These data unequivocally defined the role of Stat5 in regulating the expression of PPAR
mRNA from the early phase of differentiation. C/EBP
mRNA increased as cells differentiate in both L1-wt-Stat5 and L1-dn-Stat5 cells (Fig. 4A
, lane 5, C/EBP
). Overexpression of wt-Stat5A resulted in earlier induction of C/EBP
in L1-wt-Stat5 (Fig. 4A
, compare lanes 35 and lanes 810), whereas induction of dn-Stat5A decreased C/EBP
expression in L1-dn-Stat5 cells by d 9 (Fig. 4A
, compare lanes 5 and 10). SREBP1c was induced very early in both L1-wt-Stat5 and L1-dn-Stat5 cells (Fig. 4A
, lanes 15, SREBP1c). Overexpression of wt-Stat5A or dn-Stat5A resulted in a slight increment or decrement of the SREBP1c at d 9, respectively (compare Fig. 4A
, lanes 5 and 10, SREBP1c). Addition of Dox to parental cells did not alter the level of C/EBPß, -
, PPAR
, C/EBP
, or SREBP1c, implying that Dox alone had no impact on the expression of these transcription factors (Fig. 4A
).

View larger version (41K):
[in this window]
[in a new window]
|
Figure 4. Effects of Stat5A on the Expression of the Proadipogenic Transcription Factors
A, Ectopic expression of exogenous Stat5A affects expression of the proadipogenic transcription factors. L1-wt-Stat5 (WT), L1-dn-Stat5 (DN), and parent cells were cultured to confluence and induced to differentiate in the presence (+) or absence (-) of Dox as described in Fig. 1 except that Dox was added 48 h before hormone challenge. Total RNA was extracted at the indicated time, and 2 µg of each sample were subjected to Northern blot analysis with the antisense riboprobes corresponding to each gene. Three independent experiments were performed in duplicate, and essentially identical results were obtained. B, Wt-Stat5A stimulates the expression of PPAR , whereas dn-Stat5A represses its expression during adipocyte differentiation. L1-wt-Stat5 (WT), L1-dn-Stat5 (DN), and parent cells were cultured to confluence and induced to differentiate in the presence (+) or absence (-) of Dox as described in Fig. 4A . Whole-cell lysate was extracted at the indicated time, and 30 µg of each sample were used for PPAR Western blot analysis.
|
|
The effect of Stat5 on PPAR
expression was further confirmed at the protein level. In parent cells the amount of PPAR
increased as the cell differentiated in the absence of Dox (Fig. 4B
, parent, lanes 15). Addition of Dox to parent cells did not alter the level of PPAR
(Fig. 4B
, parent, lanes 610). However, Dox treatment resulted in enhanced expression of PPAR
from d 1 to d 7 in L1-wt-Stat5 cells, whereas a profile of PPAR
expression similar to that of parent cells was observed in the absence of Dox (Fig. 4B
, WT and parent, compare lanes 15 and lanes 610). On the other hand, expression of dn-Stat5A repressed the expression of PPAR
from d 1 to d 7, whereas L1-dn-Stat5 cells showed identical protein expression profiles as Parent cells in the absence of Dox (Fig. 4B
, DN and parent, compare lanes 15 and lanes 610). These data are in line with the hypothesis that Stat5 regulates the expression of PPAR
from the early phase of differentiation and suggest PPAR
to be a direct target of Stat5. Intriguingly, a putative Stat5-consensus motif was present in the highly conserved domains of the human and mouse PPAR
2 promoter. Our preliminary data indicated that the mouse PPAR
2 promoter could be activated by Stat5 (Nanbu-Wakao, R., and H. Wakao, unpublished results).
Dn-Stat5A Expression in Adipose Tissue Results in Repression of PPAR
We have generated transgenic mice that express another form of dn-Stat5A in fat tissues with the aP2 enhancer/promoter to unequivocally demonstrate a role of Stat5 in adipogenesis in vivo (45). We used Stat5A with a COOH-terminal transactivation domain deletion as dn-Stat5A (46). The amount of WAT is reduced in the transgenic animals (data not shown). Northern blot analysis revealed that the transgenic animal indeed expressed the truncated form of Stat5A in WAT (Fig. 5
). As expected from in vitro data, the expression of PPAR
, C/EBP
, and SREBP1c was reduced in the transgenic animal. It is noteworthy that dn-Stat5A partially blocked the expression of C/EBPß, whereas that of C/EBP
was not influenced. As PPAR
and C/EBP
regulate expression of the adipocyte-specific gene, aP2 (47, 48), we examined whether dn-Stat5A affected its expression. As can be seen in Fig. 5
, aP2 was reduced in the transgenic animal. In addition to aP2, the expression of adiponectin, a fat-derived hormone, was also repressed in the transgenic animal. In toto, these data demonstrated that Stat5 controlled expression of the proadipogenic factors such as PPAR
, C/EBP
, and SREBP1c as well as of adipocyte-specific genes during adipogenesis.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 5. Dn-Stat5A Represses the Expression of PPAR and of Adipocyte-Specific Genes in Vivo
Total WAT RNA was extracted from 26-wk-old transgenic mice (Tg) and from the age-matched littermate (WT). An equal amount of the RNA (3 µg) was subjected to Northern Blot analysis with the digoxigenin-labeled riboprobe corresponding to each gene. Expression of the truncated form of Stat5A is indicated by an arrow.
|
|
 |
DISCUSSION
|
---|
3T3-L1 cells mimic the WAT cell differentiation in vitro, and a previous study has shown that Stat5 is present throughout 3T3-L1 cell differentiation (34). Although it is reported that Stat5 is tyrosine phosphorylated upon adipogenic hormone challenge (49), our present study further clarified that Stat5A and B are activated immediately and Stat5A was kept activated throughout adipogenic conversion of 3T3-L1. These data support the hypothesis that the Stat5 pathway is continuously influencing adipogenesis (Fig. 1
). Particularly, strong activation of Stat5 at very early stages of adipogenesis implied that Stat5 plays some roles during the clonal expansion phase. Although Stat5A and B increased along with differentiation, the physiological relevance of this is yet to be explored (34) (Fig. 1
). Because tyrosine phosphorylation of Stat5A was attenuated as differentiation proceeded but not extinguished, it is possible that prolonged activation may be required for maintaining differentiation (Fig. 1
). Gene disruption experiments have disclosed that Stat5A and B are mainly responsible for GH and prolactin signaling (50). It is apparent from our results that both prolactin and FBS lead to Stat5 activation (Fig. 2B
). Because prolactin, GH, and probably IGF-I, which all activate Stat5 or enhance activation of Stat5, are components of FBS, these hormones might be primary inducers for Stat5 activation (3, 51, 52). Intriguingly, these hormones can stimulate adipogenesis (8, 31). In agreement with these notions, reduction in body weight and in fat mass was observed in prolactin receptor knockout mice and in Stat5A, B double knockout mice (50, 53), although a leaner mouse is not direct evidence of a defect in adipogenesis. Involvement of the Stat5 signaling in adipogenesis is also suggested in 3T3-F442A cells, the differentiation of which is dependent on GH (54).
In this report we have generated reciprocal systems in which either the wt or dn form of Stat5A could be induced to gain insights into the mechanisms of Stat5 action in adipogenesis. Effects of exogenous Stat5s on endogenous signaling pathways have been addressed by transfecting a Stat5-dependent reporter gene into L1-dn-Stat5 and L1-wt-Stat5 cells (Fig. 2B
). Results from these experiments further underpin the notion that exogenous Stat5s indeed impinge upon endogenous signaling pathways, resulting in either positive or negative output. Although we observed that Dox caused a 3-fold increase in basal luciferase activity in L1-wt-Stat5 cells (Fig. 2B
), this might be due to the presence of insulin in the starvation medium. In fact, insulin is reported to activate Stat5 (55).
The fact that wt- or dn-Stat5A overexpression did not affect cell proliferation implies that Stat5 activation is unrelated to cell cycle progression in 3T3-L1 cells (Fig. 2C
). A similar observation is seen in a leukemia cell line in which erythropoietin-dependent hemoglobin synthesis is solely dependent on Stat5 activation but not on cell growth (56). This is in clear contrast to the close relationship of Stat5 activation to the cell cycle progression in several hematopoietic and lymphoid cells (39, 41, 42, 57). Because the effects of dn-Stat5A on the endogenous Stat5 signaling pathways are partial (Fig. 2B
), we cannot exclude the possibility that the activity of dn-Stat5A is not sufficient to impinge upon cell proliferation. Our Dox-inducible system also allowed delimiting the time window during which Stat5 effectively influences the adipogenic program. Stat5 exerted its maximal effect on triglyceride accumulation when ectopically expressed simultaneously to the adipogenic hormone treatment. This indicates that precocious activation of this factor is important for induction of PPAR
and subsequent cell fate (Figs. 1
and 3B
).
An earlier study has suggested that expression of PPAR
is mediated by C/EBPß and/or -
(19). However, C/EBPß and -
double-knockout mice experiments indicate the presence of other pathways leading to PPAR
induction (15). In accordance with this, our present study demonstrated that Stat5 regulates, at least in part, the expression of PPAR
and C/EBP
, without affecting C/EBPß and
(Fig. 4A
). Indeed, activation of Stat5s precedes expression of these factors (Fig. 1
). Obviously, there are caveats to these conclusions based solely on studies with in vitro data. However, data from aP2-driven dn-Stat5A transgenic mice further reinforce in vitro results (Figs. 4A
and 5
). This allows us to conclude that Stat5 plays a role in adipogenesis both in vitro and in vivo. Although the expression of Stat5A affected PPAR
in a C/EBPß- and C/EBP
-independent manner in 3T3-L1 cells, C/EBPß was slightly reduced in transgenic mice (Fig. 5
). This may be due to a different potential of two types of the dn forms employed in the study. It is possible that the C-terminal truncated form of Stat5A exerts more potent dn effect than that of Y694F mutant. Alternatively, there may be another signaling pathway interfering with the expression of C/EBPß in vivo. PPAR
gene ablation resulted in decrease of the many adipocyte-related genes including aP2 and C/EBP
. (22, 23). Given that Stat5 regulates the expression of PPAR
, it is not surprising that expression of the PPAR
-controlled genes are repressed by dn-Stat5A both in vitro and in vivo (Figs. 4A
and 5
). Analysis of other adipocyte-specific gene expression will reveal whether their expression is dependent on Stat5-PPAR
or not.
Taking all into account, we would like to present a working model by which Stat5 stimulates adipogenesis (Fig. 6
). Stat5 is activated following adipogenic hormone challenge and stimulates, either directly or through transcription of as-yet-unidentified genes, the expression of C/EBP
and PPAR
. These proadipogenic factors, in turn, induce a series of adipocyte-related genes such as aP2 and adiponectin. Enhanced expression of these genes and of lipogenic enzymes results in increased triglyceride accumulation within the cells. Therefore, Stat5 appears to be an initial transcription factor involved in adipogenesis and constitutes a direct link between external signals to the intracellular transcriptional cascade leading to execution of the differentiation program.
Obviously, it is tenuous to conclude that Stat5 is the key transcription factor that initiates the adipocyte differentiation program. Induction of dn-Stat5A at an early phase of differentiation resulted in partial inhibition of triglyceride accumulation (Fig. 3B
, DN). Inducible expression of wt-Stat5A alone in the absence of MIX and DEX was not sufficient to initiate adipogenesis (Nanbu-Wakao, R., and H. Wakao, unpublished results). Optimal differentiation of 3T3-L1 cells is dependent on the presence of FBS, MIX, DEX, and insulin. Deprivation of one or more components results in attenuation of the differentiation potential of the cells (14). This indicates that there must be several factors simultaneously activated by these hormones. As mentioned earlier, C/EBPß and -
are transcriptionally induced by MIX and DEX, respectively (12). In contrast, Stat5 is activated posttranslationally, as demonstrated in this study. A recent report has also shown that activation of cAMP response element binding protein (CREB) is necessary and sufficient to induce adipogenesis (58). A similar activation profile between CREB and Stat5 during adipocyte differentiation implies that these pathways function in parallel to promote adipogenesis. While the contribution of CREB explains, at least in part, the requirement of cAMP in adipogenesis, Stat5 may play as a mediator of FBS that optimizes differentiation. Another pathway to be considered is Wnt signaling, which is shown to inhibit adipocyte differentiation (59). Because Stat5 and Wnt exhibit an opposite effect on the expression of PPAR
and C/EBP
as well as on adipogenesis, it will be interesting to examine whether there is any cross-talk between Wnt and Stat5 signaling. A previous report has indicated that glucocorticoid induces PPAR
expression in a dose-dependent fashion (19). Given that Stat5 is responsible for the induction of PPAR
, a direct interaction between Stat5 and the glucocorticoid receptor can be envisaged for this induction. In fact, a synergistic output elicited from such an interaction has been reported (60). In this regard, involvement of glucocorticoid receptor and Stat5 may explain, at least in part, the requirement of DEX for PPAR
and C/EBP
expression as well as for maximal differentiation of 3T3-L1 cells (14).
Finally, it is noteworthy that not only is Stat5 involved in adipogenesis, but it also plays a mandatory role in mammopoiesis, particularly in alveoli formation in vivo (61, 62). Mammary epithelial cell differentiation in vitro is reminiscent of adipocyte differentiation in that both systems require the cells to be confluent before treatment with hormones comprising a similar but not identical cocktail (63, 64). In both cases, Stat5 is immediately activated upon hormone challenge (present study and Ref. 65). These observations indicate that Stat5 triggers cell differentiation in concert with other intracellular signaling molecules. Intriguingly, it is shown that activation of the Jak-Stat pathway is required for the self-renewal of stem cells in Drosophila (66, 67). Identification of Jak-Stat targeting genes will shed light on the molecular mechanisms underlying these phenomena. In the absence of a Stat5-specific inhibitor, our Dox-controlled expression system will allow identification of Stat5-regulated genes in adipogenesis. Molecular characterization of these genes will further our knowledge of adipocyte differentiation.
 |
MATERIALS AND METHODS
|
---|
Materials
Bovine insulin and DEX were purchased from Sigma (St. Louis, MO), and methylisobutylxanthine was from Wako Chemical Co. (Osaka, Japan).
Plasmids and cDNA
The cDNAs for C/EBP
, C/EBPß, C/EBP
, PPAR
2, and aP2 were isolated from a 3T3-L1 preadipocyte library in pZL1 constructed at 9 d after the induction of differentiation by using the SuperScriptII
system (Invitrogen, San Diego, CA) as described previously (31). Other cDNAs were prepared by RT-PCR as follows. First-strand cDNA was prepared from 3T3-L1 total RNA by using an RNA PCR (AMV) Ver2.1 kit (Takara, Ohtsu, Japan). The cDNAs were then used as templates in PCRs with the indicated primer sets. The resulting PCR products were subcloned into the pGEM-7Zf(+) vector (Promega Corp., Madison, WI). The primer sequences used in this study were as follows. ADD1/SREBP-1c, 5'-GACCCTGGTGAGTGGNGGAAC-3' (sense), 5'-GAGGCCAANGGGTTGCAGGNC-3' (antisense). Adiponectin, 5'-ATGCTACTGTTGCAAGCTCTCCT-3' (sense), 5'-TCAGTTGGTATCATGGTAGAGAAG-3' (antisense). All cDNA sequences were verified by DNA sequencing (ABI 377 DNA sequencer; Applied Biosystems, Foster City, CA).
Cell Culture and Induction Of Differentiation
3T3-L1 preadipocytes (NIHS cell bank, Japan, catalogue no. JCRB9014) were maintained in growth medium consisting of DMEM (Nisseiken, Kyoto, Japan) containing 10% normal calf serum. To differentiate 3T3-L1 cells, cells were grown to confluence and left for 2 d. Cells were then exposed to fresh differentiation medium consisting of DMEM, 10% FBS, 1 µM DEX, 0.5 mM MIX, and 10 µg/ml of insulin for 48 h. Thereafter cells were refed every other day with DMEM containing 10% FBS and 2.5 µg/ml of insulin. Differentiation was confirmed by Oil Red O staining of lipid vesicles. Triglycerides from differentiated cells were extracted with isopropanol and quantitated with a Triglycerides Test kit (Wako Chemical Co.). Cells were counted with a hemocytoanalyzer CDA-500 (Sysmex, Kobe, Japan).
Construction of the Dox-Inducible Expression Systems for Stat5
To establish inducible Stat5A expression cell lines, we used the rtTA system (36), in which transcription of a target gene is initiated by Dox treatment. 3T3-L1 cells were first transfected with pUD1722neo (rtTA), and clones were selected in the presence of 0.4 mg/ml of G418. G418-resistant clones were assessed for their rtTA-dependent reporter gene expression by supertransfecting pUHC133. A clone that showed the greatest Dox-dependent luciferase activity was isolated, termed parent, and used for further construction. The expression vectors for wt-Stat5A and for dn-Stat5A (Y694F) were constructed by ligating an EcoRI-NotI fragment containing ovine Stat5 or Stat5 (Y694F), which corresponds to mouse Stat5A, into the modified multicloning site of pUHD103. These vectors were transfected together with pPUR (CLONTECH Laboratories, Inc., Palo Alto, CA) into parent cells. Clones were selected in the presence of 3 µg/ml of puromycin and then monitored for their Dox-dependent induction of Stat5 by Western blot analysis.
RNA Analysis
Total RNA, isolated according to the method of Chomczynski and Sacchi (68), was fractionated on a 1% agarose gel with a Northern Max-Gly kit (Ambion, Inc., Austin, TX) and transferred to a nylon membrane. rRNA was stained on the filters with methylene blue to assess RNA loading and transfer efficiency. Digoxigenin-labeled antisense RNA probes were synthesized with SP6/T7 RNA polymerase from linearized plasmids. Hybridization and washing were performed according to the protocol provided by the supplier (Roche Molecular Biology, Basel, Switzerland).
Immunoprecipitation and Immunoblotting
Whole-cell extracts from 3T3-L1 cells were prepared at the indicated time points with lysis buffer (50 mM HEPES-NaOH, pH 7.8; 150 mM NaCl; 1% Triton X-100; 50 mM NaF; 1 mM Na3VO4; 30 mM sodium pyrophosphate; 1 mM Pefablock; 0.1 mg/ml leupeptin). Cells were lysed on ice for 60 min, and insoluble materials were pelleted by centrifugation. Protein concentration was determined with a BCA protein assay kit (Pierce Chemical Co., Rockford, IL). Clarified lysates were incubated with antiserum against Stat5A and B proteins. After an overnight incubation with protein A-coupled beads, the immunoprecipitates were electrophoresed on a 10% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. Immunoprecipitated proteins were blotted with 4G10 and then reblotted with the respective antibody. Anti-Stat5A (L-20), Stat5B (C-17), and anti-PPAR
(H-100) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Dox-Dependent Transcriptional Activation Assay
Forty-eight hours before transfection, L1-wt-Stat5 or L1-dn-Stat5 cells were treated with Dox or left untreated. At 5060% confluence, cells were transfected with a Stat5-reporter plasmid together with the renilla luciferase expression vector (pRL-cytomegalovirus) to control the transfection efficiency (Promega Corp.) (40). After DNA removal, cells were serum starved for 16 h in OPTIMEM (Life Technologies, Inc., Gaithersburg, MD) and then left untreated or challenged with prolactin or FBS. Cells were lysed, and both firefly and renilla luciferase activities were measured.
Construction of aP2-Driven dn-Stat5 Transgenic Mice
The 5.4-kb aP2 promoter/enhancer was cloned by long and accurate-PCR (Takara Co., Ohtsu, Japan) (45). The C-terminal deletion mutant of Stat5A was digested with EcoRI and XbaI from pXM vector (a gift from Dr. B. Groner). After blunting, the truncated Stat5A was cloned into a vector containing the rabbit ß-globin poly (A). Then the truncated-Stat5A-rabbit ß-globin poly (A) was cloned into XbaI-ClaI sites of pBlue Script IIKS(+) (Stratagene, La Jolla, CA). After digestion with XbaI and blunting, a phosphorylated 5.4-kb aP2 promoter/enhancer was inserted. The resulting 9.1-kb aP2 truncated-Stat5A rabbit ß-globin poly (A) construct was cleaved with SalI and NotI and purified on agarose gel. The integrity of the plasmid was confirmed by DNA sequencing of the ligation junctions. The purified DNA was microinjected into more than 200 fertilized eggs of C57BL/6CrSlc (SLC Co., Hamamatsu, Japan). Among the 18 offspring, 5 had integrated the transgene as determined by PCR on tail DNA with transgene-specific primers (5'-ACATACAGGGTCTGGTCATG-3' and 5'-CGCCTTCTTCTGCAGCTCGT-3', giving 422 bp). Mice with high levels of transgene expression were bred to C57BL/6J mice, and several independent lines of transgenic mice were established. Mice were housed in colony cages and maintained on a 12-h light, 12-h dark cycle. Data from representative mice were shown.
 |
ACKNOWLEDGMENTS
|
---|
We thank Professor Herman Bujard (University of California, Berkeley, CA) for providing us with the pUD1722neo, pUHC133, and pUHD103 plasmids, and Dr. Bernd Groner (Frankfurt, Germany) for C-terminal truncated Stat5A cDNA.
 |
FOOTNOTES
|
---|
Helix Research Institute is supported by the Ministry of International Trade and Industry (MITI), Chugai Pharmaceutical Co., Fujisawa Pharmaceutical Co., Ltd., Hitachi Co., Mitsubishi Chemical Co., Japan Financing Co. (JAFCO), Kyowa Hakko Co., Sumitomo Chemical Co., Taisho Pharmaceutical Co., Yamanouchi Pharmaceutical Co., Ltd., and Yoshitomi Pharmaceutical Co.
Abbreviations: C/EBP, CCAAT-enhancer binding protein; CREB, cAMP response element binding protein; DEX, dexamethasone; dn, dominant negative; Dox, doxycycline; FBS, fetal bovine serum; MIX, methylisobutylxanthine; PPAR, peroxisome proliferator-activated receptor; rtTA, reverse tetracycline-controlled transactivator; Stat, signal transducer and activator of transcription; WAT, white adipose tissue; wt, wild type.
Received for publication May 14, 2001.
Accepted for publication March 6, 2002.
 |
REFERENCES
|
---|
- Cornelius P, MacDougald OA, Lane MD 1994 Regulation of adipocyte development. Annu Rev Nutr 14:99129[CrossRef][Medline]
- Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA 2001 The hormone resistin links obesity to diabetes. Nature 409:307312[CrossRef][Medline]
- Gregoire FM, Smas CM, Sul HS 1998 Understanding adipocyte differentiation. Physiol Rev 78:783809[Abstract/Free Full Text]
- Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K 1996 cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286289[CrossRef][Medline]
- Kahn BB, Flier JS 2000 Obesity and insulin resistance. J Clin Invest 106:473481[Free Full Text]
- Hotamisligil GS 1999 The role of TNF
and TNF receptors in obesity and insulin resistance. J Intern Med 245:621625[CrossRef][Medline]
- Kahn BB 1996 Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes 45:16441654[Abstract]
- MacDougald OA, Lane MD 1995 Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64:345373[CrossRef][Medline]
- Fajas L, Fruchart JC, Auwerx J 1998 Transcriptional control of adipogenesis. Curr Opin Cell Biol 10:165173[CrossRef][Medline]
- Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM 2000 Transcriptional regulation of adipogenesis. Genes Dev 14:12931307[Free Full Text]
- Morrison RF, Farmer SR 1999 Insights into the transcriptional control of adipocyte differentiation. J Cell Biochem Suppl:5967
- Cao Z, Umek RM, McKnight SL 1991 Regulated expression of three C/EBP isoforms during adipose conversion of 3T3L1 cells. Genes Dev 5:15381552[Abstract]
- Wu Z, Xie Y, Bucher NL, Farmer SR 1995 Conditional ectopic expression of C/EBPß in NIH-3T3 cells induces PPAR
and stimulates adipogenesis. Genes Dev 9:23502363[Abstract]
- Yeh WC, Cao Z, Classon M, McKnight SL 1995 Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9:168181[Abstract]
- Tanaka T, Yoshida N, Kishimoto T, Akira S 1997 Defective adipocyte differentiation in mice lacking the C/EBPß and/or C/EBP
gene. EMBO J 16:74327443[Abstract/Free Full Text]
- Lin FT, Lane MD 1994 CCAAT/enhancer binding protein
is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 91:87578761[Abstract]
- Freytag SO, Paielli DL, Gilbert JD 1994 Ectopic expression of the CCAAT/enhancer-binding protein
promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 8:16541663[Abstract]
- Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayad SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ 1995 Impaired energy homeostasis in C/EBP
knockout mice. Science 269:11081112[Medline]
- Wu Z, Bucher NL, Farmer SR 1996 Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPß, C/EBP
, and glucocorticoids. Mol Cell Biol 16:41284136[Abstract]
- Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPAR
2, a lipid-activated transcription factor. Cell 79:11471156[Medline]
- Hu E, Tontonoz P, Spiegelman BM 1995 Transdifferentiation of myoblasts by the adipogenic transcription PPAR
and C/EBP
. Proc Natl Acad Sci USA 92:98569860[Abstract]
- Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Speigelman BM, Mortensen RM 1999 PPAR
is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611617[Medline]
- Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Nagai R, Tobe K, Kimura S, Kadowaki T 1999 PPAR
mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597609[Medline]
- Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM 1999 PPAR
is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585595[Medline]
- Tontonoz P, Kim JB, Graves RA, Spiegelman BM 1993 ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 13:47534759[Abstract]
- Kim JB, Spiegelman BM 1996 ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10:10961107[Abstract]
- Fajas L, Schoonjans K, Gelman L, Kim JB, Najib J, Martin G, Fruchart JC, Briggs M, Spiegelman BM, Auwerx J 1999 Regulation of peroxisome proliferator-activated receptor
expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol 19:54955503[Abstract/Free Full Text]
- Kim JB, Wright HM, Wright M, Spiegelman BM 1998 ADD1/SREBP1 activates PPAR
through the production of endogenous ligand. Proc Natl Acad Sci USA 95:43334337[Abstract/Free Full Text]
- McAveney KM, Gimble JM, Yu-Lee L 1996 Prolactin receptor expression during adipocyte differentiation of bone marrow stroma. Endocrinology 137:57235726[Abstract]
- Zou L, Menon RK, Sperling MA 1997 Induction of mRNAs for the growth hormone receptor gene during mouse 3T3-L1 preadipocyte differentiation. Metabolism 46:114118[Medline]
- Nanbu-Wakao R, Fujitani Y, Masuho Y, Muramatu M, Wakao H 2000 Prolactin enhances CCAAT enhancer-binding protein-ß (C/EBP ß) and peroxisome proliferator-activated receptor
(PPAR
) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 14:307316[Abstract/Free Full Text]
- Mui AL, Wakao H, OFarrell AM, Harada N, Miyajima A 1995 Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J 14:11661175[Abstract]
- Schindler C, Darnell Jr JE 1995 Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64:621651[CrossRef][Medline]
- Stephens JM, Morrison RF, Pilch PF 1996 The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem 271:1044110444[Abstract/Free Full Text]
- Stephens JM, Morrison RF, Wu Z, Farmer SR 1999 PPAR
ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis. Biochem Biophys Res Commun 262:216222[CrossRef][Medline]
- Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H 1995 Transcriptional activation by tetracyclines in mammalian cells. Science 268:17661769[Medline]
- Chin H, Wakao H, Miyajima A, Kamiyama R, Miyasaka N, Miura O 1997 Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor ß subunit (ßIL3) and recruitment of Stat5 to possible Stat5-docking sites in ßIL3. Blood 89:43274336[Abstract/Free Full Text]
- Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y, Kanakura Y 1997 Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5. Mol Cell Biol 17:29332943[Abstract]
- Welte T, Leitenberg D, Dittel BN, al-Ramadi BK, Hansen WR, Xie B, Janeway Jr CA, Bothwell AL, Bottomly K, Fu XY 1999 STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 283:222225[Abstract/Free Full Text]
- Matsumura I, Nakajima K, Wakao H, Hattori S, Hashimoto K, Sugahara K, Koto T, Miyazaki H, Hirano T, Kanakura Y 1998 Involvement of prolonged ras activation in thrombopoietininduced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol 18:42824290[Abstract/Free Full Text]
- Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL, Krystal G 1995 Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J 14:55575568[Abstract]
- Mui AL, Wakao H, Kinoshita T, Kitamura T, Miyajima A 1996 Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J 15:24252433[Abstract]
- Lyle RE, Richon VM, McGehee Jr RE 1998 TNF
disrupts mitotic clonal expansion and regulation of retinoblastoma proteins p130 and p107 during 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun 247:373378[CrossRef][Medline]
- Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG, Kanakura Y 1999 Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J 18:13671377[Abstract/Free Full Text]
- Ross SR, Graves RA, Greenstein A, Platt KA, Shyu HL, Mellovitz B, Spiegelman BM 1990 A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc Natl Acad Sci USA 87:95909594[Abstract]
- Moriggl R, Gouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F 1996 Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol 16:56915700[Abstract]
- Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM 1994 mPPAR
2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:12241234[Abstract]
- Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM 1995 PPAR
2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15:351357[Abstract]
- Balhoff JP, Stephens JM 1998 Highly specific and quantitative activation of STATs in 3T3-L1. Biochem Biophys Res Commun 247:894900[CrossRef][Medline]
- Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN 1998 Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841850[Medline]
- Wakao H, Gouilleux F, Groner B 1994 Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 13:21822191[Abstract]
- Okajima Y, Matsumura I, Nishiura T, Hashimoto K, Yoshida H, Ishikawa J, Wakao H, Yoshimura A, Kanakura Y, Tomiyama Y, Matsuzawa Y 1998 Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. J Biol Chem 273:2287722883[Abstract/Free Full Text]
- Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P 2001 Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 142:532537[Abstract/Free Full Text]
- Yarwood SJ, Sale EM, Sale GJ, Houslay MD, Kilgour E, Anderson NG 1999 Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling. J Biol Chem 274:86628668[Abstract/Free Full Text]
- Chen J, Sadowski HB, Kohanski RA, Wang LH 1997 Stat5 is a physiological substrate of the insulin receptor. Proc Natl Acad Sci USA 94:22952300[Abstract/Free Full Text]
- Wakao H, Chida D, Damen JE, Krystal G, Miyajima A 1997 A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis. Biochem Biophys Res Commun 234:198205[CrossRef][Medline]
- Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Piekorz R, Wang D, Parganas E, Yoshimura A 1999 Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249259[Medline]
- Reusch JE, Colton LA, Klemm DJ 2000 CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol 20:10081020[Abstract/Free Full Text]
- Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA 2000 Inhibition of adipogenesis by Wnt signaling. Science 289:950953[Abstract/Free Full Text]
- Stocklin E, Wissler M, Gouilleux F, Groner B 1996 Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726728[CrossRef][Medline]
- Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11:179186[Abstract]
- Miyoshi K, Shillingford JM, Smith GH, Grimm SL, Wagner KU, Oka T, Rosen JM, Robinson GW, Hennighausen L 2001 Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol 155:531542[Abstract/Free Full Text]
- Green H, Kehinde O 1975 An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell 5:1927[Medline]
- Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B 1988 Prolactin regulation of ß-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J 7:20892095[Abstract]
- Wartmann M, Cella N, Hofer P, Groner B, Liu X, Hennighausen L, Hynes NE 1996 Lactogenic hormone activation of Stat5 and transcription of the ß-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity. J Biol Chem 271:3186331868[Abstract/Free Full Text]
- Kiger AA, Jones DL, Schulz C, Rogers MB, Fuller MT 2001 Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science 294:25422545[Abstract/Free Full Text]
- Tulina N, Matunis E 2001 Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling. Science 294:25462549[Abstract/Free Full Text]
- Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156159[CrossRef][Medline]